Effective 9/27/24, TEGSEDI^® (inotersen) will no longer be available to patients in the US. We encourage you to connect with your patient or healthcare provider on a treatment transition plan. Sobi remains committed to supporting patients through their transition. Please contact Akcea Connect at 1-866-252-3289 with questions about patient support.